Pharmacology & ToxicologybioRxivPreprint
Discovery and characterization of highly potent and selective covalent inhibitors of SARS-CoV-2 PLpro
This study identifies and characterizes two covalent PLpro inhibitors, HUP0109 and DX-027, as potential treatments for SARS-CoV-2.
DOI 10.1101/2023.05.02.539082